In NF1 patients, a microscopically positive margin (R1) was the only risk factor for LR development (HR 2.1; 95% CI, 1.19-3.79).<h4>Conclusions</h4>RTx is frequently used in the treatment of MPNSTs, regardless of NF1 status. Here, NF1 is linked to neurofibromatosis type 1.